Therapeutic Indications

Cefuroxime is indicated for:

Urinary tract, soft-tissue, intra-abdominal and wound infections

Irrespective of gender only Newborns (0 - 40 days old) , Infants (40 days - 1 year old) , Children (1 year - 12 years old)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 30-100 mg/kg in 3 doses daily

Treatment 2: Oral - 30 mg/kg in 2 doses daily

Acute tonsillitis and pharyngitis, acute bacterial sinusitis

Irrespective of gender only Newborns (0 - 40 days old) , Infants (40 days - 1 year old) , Children (1 year - 12 years old)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 20 mg/kg in 2 doses daily

Lyme disease

Irrespective of gender only Newborns (0 - 40 days old) , Infants (40 days - 1 year old) , Children (1 year - 12 years old)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 30 mg/kg in 2 doses daily

Acute otitis media

Irrespective of gender only Newborns (0 - 40 days old) , Infants (40 days - 1 year old) , Children (1 year - 12 years old)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 30 mg/kg in 2 doses daily

Community acquired pneumonia

Irrespective of gender only Newborns (0 - 40 days old) , Infants (40 days - 1 year old) , Children (1 year - 12 years old)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 30-100 mg/kg in 3 doses daily

Soft-tissue infections, cellulitis, erysipelas, wound infections

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intramuscular - 2250 mg in 3 divided doses daily

Treatment 2: Intravenous - 2250 mg in 3 divided doses daily

Treatment 3: Oral - 500 mg in 2 divided doses daily

Acute tonsillitis and pharyngitis, acute bacterial sinusitis

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 500 mg in 2 divided doses daily

Intra-abdominal infections

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intramuscular - 2250 mg in 3 divided doses daily

Treatment 2: Intravenous - 2250 mg in 3 divided doses daily

Surgical prophylaxis for gastrointestinal, gynaecological and orthopaedic operations

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 1500 mg with the induction of anaesthesia and 2 doses of 750 mg after 8 hours and 16 hours

Surgical prophylaxis for cardiovascular and oesophageal operations

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 1500 mg with the induction of anaesthesia and 3 doses of 750 mg after 8 hours and 16 hours

Lyme disease

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 1000 mg in 2 divided doses daily

Acute otitis media

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 1000 mg in 2 divided doses daily

Community acquired pneumonia

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 2250 mg in 3 divided doses daily

Treatment 2: Intramuscular - 2250 mg in 3 divided doses daily

Acute exacerbation of chronic bronchitis

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 2250 mg in 3 divided doses daily

Treatment 2: Intramuscular - 2250 mg in 3 divided doses daily

Treatment 3: Oral - 1000 mg in 2 divided doses daily

Complicated urinary tract infections

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 4.5 g in 3 divided doses daily

Treatment 2: Oral - 500 mg in 2 divided doses daily

Contraindications

Active ingredient Cefuroxime is contraindicated in the following cases:

Hypersensitivity to cephalosporin antibiotics

No gender/age discrimination